SeaStar Medical is trading 9.21% down at $3.35, with no clear company-specific cause identified for the August 12, 2026 decline.
- Second-quarter 2026 results are scheduled after market close at 4:30 p.m. ET; pre-earnings caution may be contributing, but the report does not establish the reason.
- The Nasdaq is up 0.66% and the S&P 500 is up 0.22%, leaving SeaStar Medical underperforming broader sentiment.
- Trading-volume data was not provided.